ホーム>>Met-Enkephalin (trifluoroacetate salt)

Met-Enkephalin (trifluoroacetate salt) (Synonyms: Met5-Enkephalin, Methionine-Enkephalin)

カタログ番号GC44171

メト-エンケファリンは、痛覚に関与する内因性の神経ペプチドであり、δ-およびμオピオイド受容体のアゴニストです(それぞれKis = 0.65および1.7 nM)。

Products are for research use only. Not for human use. We do not sell to patients.

Met-Enkephalin (trifluoroacetate salt) 化学構造

サイズ 価格 在庫数 個数
5mg
$83.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Met-Enkephalin is an endogenous neuropeptide involved in nociception and an agonist of δ- and µ-opioid receptors (Kis = 0.65 and 1.7 nM, respectively). It is selective for δ- and µ- over κ-opioid receptors (Ki = >1,000 nM). Met-Enkephalin is a cleavage product of proenkephalin, which is found primarily in the adrenal medulla and the CNS. Met-Enkephalin is found in the brain, primarily in the globus pallidus, nucleus accumbens, and substantia nigra, the brainstem, and the spinal cord as well as in the peripheral nervous system. Met-Enkephalin has antinociceptive effects in mouse models of acute pain, including tail pressure, hot plate tail-flick, and acetic acid-induced writhing tests (ED50s = 170, 140, and 88 nmol/animal, respectively). Levels of Met-enkephalin are increased at the site of inflammation in a complete Freund's adjuvant mouse model of chronic inflammatory pain.

レビュー

Review for Met-Enkephalin (trifluoroacetate salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 21 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Met-Enkephalin (trifluoroacetate salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.